Jan 28, 2009
Notice
Kringle Pharma Commences a Phase I/II Clinical Trial in Sweden on ChronSeal, a Recombinant Human HGF-Based Therapy for the Treatment of Skin Ulcers.
Kringle Pharma Commences a Phase I/II Clinical Trial in Sweden on ChronSeal®, a Recombinant Human HGF-Based Therapy for the Treatment of Skin Ulcers.